Method for improving the half-life of soluble viral receptors on mucosal membranes
Patent Information
- Authority / Receiving Office
- US ยท United States
- Patent Type
- Applications(United States)
- Current Assignee / Owner
- OSEL
- Publication Date
- 2002-07-04
- Estimated Expiration
- Not applicable ยท inactive patent
Smart Images

Figure 1 
Figure 2
Abstract
Description
CROSS-REFERENCES TO RELATED APPLICATIONS
[0001] This application claims the priority of U.S. Provisional Application No. 60 / 129,722, filed on Apr. 16, 1999, the disclosure of which is hereby incorporated by reference.STATEMENT AS TO RIGHTS TO INVENTIONS MADE UNDER FEDERALLY SPONSORED RESEARCH AND DEVELOPMENT
[0002] Not applicable.
[0003] The use of soluble viral receptors to prevent viral infection is being actively pursued. Amongst these efforts, intranasal administration of soluble ICAM-1 is being tested to prevent rhinovirus (cold) infection (Boehringer Ingelheim and Bayer). Soluble viral receptors are designed to work by engaging all host binding sites of a virus, thereby leaving none for the virus to attach to its target cell. However, a single viral particle has numerous binding sites for the host cell on its surface, e.g. rhinovirus has 60. Soluble viral receptors must simultaneously coat all binding sites on the virus to render it non-infectious. This requires an extremely high...